M S Hertzberg

Summary

Affiliation: University of Sydney
Country: Australia

Publications

  1. ncbi Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders
    M Hertzberg
    BMT Service, Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia
    Bone Marrow Transplant 37:923-8. 2006
  2. ncbi Achieving and maintaining quality in the laboratory
    M S Hertzberg
    Department of Haematology, ICPMR and Haematology RCPA QAP, Westmead Hospital, Westmead, NSW, Australia
    Haemophilia 12:61-7. 2006
  3. ncbi Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma
    M S Hertzberg
    Department of Haematology, Westmead Hospital, Westmead, NSW 2145, Australia
    Ann Oncol 17:iv25-30. 2006
  4. ncbi Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease
    M S Hertzberg
    Department of Haematology, Westmead Hospital, Westmead, NSW 2145, Australia
    Ann Oncol 14:i11-6. 2003
  5. doi A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group
    B George
    Department of Haematology, University of Sydney, Westmead Hospital, Sydney, New South Wales, Australia
    Transpl Infect Dis 14:141-8. 2012
  6. ncbi Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre
    K F Bradstock
    Blood and Marrow Transplant Service, Westmead Hospital, Sydney, New South Wales, Australia
    Intern Med J 36:355-61. 2006
  7. ncbi Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab
    S Ramanathan
    Department of Haematology, Westmead Hospital, Westmead, NSW 2145, Australia
    Am J Hematol 78:123-6. 2005
  8. ncbi Tuberculosis in allogeneic stem cell transplant recipients: still a problem in the 21st century
    A A Erdstein
    Department of Thoracic Medicine, Westmead Hospital and University of Sydney, Westmead, New South Wales, Australia
    Transpl Infect Dis 6:142-6. 2004

Collaborators

Detail Information

Publications8

  1. ncbi Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders
    M Hertzberg
    BMT Service, Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia
    Bone Marrow Transplant 37:923-8. 2006
    ..At a median follow-up of 48 months, overall survival probability is 80% (95% CI, 67-93%). We confirm that RIT in chronic B-LPD can result in high and durable CR rates but with significant incidences of acute and chronic GVHD...
  2. ncbi Achieving and maintaining quality in the laboratory
    M S Hertzberg
    Department of Haematology, ICPMR and Haematology RCPA QAP, Westmead Hospital, Westmead, NSW, Australia
    Haemophilia 12:61-7. 2006
    ....
  3. ncbi Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma
    M S Hertzberg
    Department of Haematology, Westmead Hospital, Westmead, NSW 2145, Australia
    Ann Oncol 17:iv25-30. 2006
    ..These data confirm the efficacy and tolerability of outpatient fractionated ICE as both a salvage and mobilisation regimen in relapsed/refractory lymphoma...
  4. ncbi Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease
    M S Hertzberg
    Department of Haematology, Westmead Hospital, Westmead, NSW 2145, Australia
    Ann Oncol 14:i11-6. 2003
    ..These data confirm the efficacy and tolerability of fractionated ICE chemotherapy as both a salvage and mobilisation regimen that can be readily delivered in an outpatient setting...
  5. doi A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group
    B George
    Department of Haematology, University of Sydney, Westmead Hospital, Sydney, New South Wales, Australia
    Transpl Infect Dis 14:141-8. 2012
    ....
  6. ncbi Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre
    K F Bradstock
    Blood and Marrow Transplant Service, Westmead Hospital, Sydney, New South Wales, Australia
    Intern Med J 36:355-61. 2006
    ....
  7. ncbi Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab
    S Ramanathan
    Department of Haematology, Westmead Hospital, Westmead, NSW 2145, Australia
    Am J Hematol 78:123-6. 2005
    ..We report herein the successful use of rituximab in the treatment of two patients with idiopathic refractory warm autoimmune hemolytic anemia, who are still in remission at 15 and 9 months following treatment...
  8. ncbi Tuberculosis in allogeneic stem cell transplant recipients: still a problem in the 21st century
    A A Erdstein
    Department of Thoracic Medicine, Westmead Hospital and University of Sydney, Westmead, New South Wales, Australia
    Transpl Infect Dis 6:142-6. 2004
    ..A higher index of suspicion of previous TB exposure and infection is required in the assessment of ASCT recipients, particularly in those born in areas where TB is common or endemic...